OBJECTIVE: It is well established that trial of labor after cesarean delivery (TOLAC) is associated with higher success rate in the presence of at least one prior vaginal delivery (VD). Yet, the magnitude of impact of each additional prior VD on the success rate is yet to be answered. Therefore, we aimed to characterize the additive effect of each additional previous VD among women attempting TOLAC. STUDY DESIGN: A retrospective cohort study of all women attempting TOLAC with singleton pregnancy at term who delivered at a single, tertiary medical center, between 2007-2014. The primary outcome was defined as mode of delivery. Secondary outcomes included uterine rupture, composite maternal morbidity (defined as 1 of the following: uterine rupture, postpartum hemorrhage, or postpartum transfusion) and composite neonatal morbidity (defined as 1 of the following: mechanical ventilation, respiratory distress syndrome, arterial cord pH<7.05, 5-minutes Apgar score<7, birth asphyxia, hypoxic-ischemic encephalopathy, or neonatal death). Women without any prior VD were compared to women with one prior VD, which were compared to women with two previous VDs, which were compared to women with three or more previous VDs ( Figure) . RESULTS: During the study period, 2,772 women were eligible for the analysis: 1,219 (44.0%) women had no prior VD, 845 (30.5%) had one prior VD, 398 (14.4%) had two prior VDs and 310 had three or more prior VDs (11.1%) (Fig 1) . Compared to no prior VD, the presence of any number of VDs was associated with higher rate of achieving vaginal delivery (p<0.001), with no significant differences between the groups who have had at least one previous VD. No differences were found with regards to the rate of uterine rupture (p¼0.4). A history of at least one previous VD increased the chance of achieving VD and decreased the risk of maternal and neonatal adverse outcomes. No such effect was found in the comparison of two previous VDs to one prior VD, or in the comparison of three or more previous VDs to two previous VDs (Table) . CONCLUSION: One prior VD improves the chances of having a VD in the index pregnancy, and additional prior VDs do not seem to increase this success rate significantly. 
OBJECTIVE:
To investigate whether the use of anti-adhesion barriers/ hemostatic agents during a cesarean section (CS) poses a risk for post CS infection STUDY DESIGN: A case control study on 113 patients who were diagnosed with post CS infection and 224 controls between the years 2012-2017 was conducted. For each patient who was diagnosed with a post CS infection we matched in a ratio of 1:2 patients who underwent the previous and subsequent CS and at the same setting (elective/urgent). Women were defined as having post CS infection if they developed at the postoperative hospitalization fever or clinical signs of infection, or were re-admitted for fever or clinical signs of infection including surgical wound infection, endometritis, urinary tract infection (UTI), infected hematoma, sepsis etc. Data regarding socio-demographic characteristics, medical and obstetrical history and surgical characteristics were retrieved from the patients' computerized records. Multivariable analyses were performed to control for confounders. RESULTS: During the study period 113 patients developed postoperative infection. Of these, 71.7% were diagnosed with surgical site infection, 7.1% with endometritis, 7.9% with infected 
